Guardian Wealth Advisors (North Carolina)’s ARK Genomic Revolution ETF ARKG Stock Holding History

Guardian Wealth Advisors (North Carolina)’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-181	Closed	-$6K	–	377
2022 Q3	$6K	Sell	181 -1	-0.5%	-$37	﹤0.01%	302
2022 Q2	$6K	Buy	182 +180	+9,000%	+$6.29K	﹤0.01%	304
2022 Q1	$0	Hold	2	–	–	﹤0.01%	249
2021 Q4	$0	Buy	+2	New	+$138	﹤0.01%	240

Other funds holding ARKG

AWA

Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

Guardian Wealth Advisors (North Carolina)'s ARKG Position: Q4 2022 in Review

Guardian Wealth Advisors (North Carolina) sold out of ARK Genomic Revolution ETF (ARKG) in Q4 2022, closing a stake of 181 shares — an estimated $6K sold.

Guardian Wealth Advisors (North Carolina) first reported a position in ARKG in Q4 2021 and held it in 4 quarters. The position peaked at $6K in Q3 2022. 320 funds tracked by Wall St. Rank hold ARKG as of Q4 2022.

Guardian Wealth Advisors (North Carolina) reported no remaining ARK Genomic Revolution ETF position as of Q4 2022 after selling out during the quarter.
Guardian Wealth Advisors (North Carolina) sold 181 ARK Genomic Revolution ETF shares in Q4 2022, an estimated $6K.
Guardian Wealth Advisors (North Carolina) first reported a position in ARK Genomic Revolution ETF in Q4 2021 and held it in 4 quarters.
Guardian Wealth Advisors (North Carolina)'s ARK Genomic Revolution ETF position peaked at $6K in Q3 2022.
320 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q4 2022.

Based on Guardian Wealth Advisors (North Carolina)'s 13F filing for Q4 2022, filed 14 Feb 2023.